These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 27783533)

  • 21. Plecanatide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: Post hoc analyses of placebo-controlled trials in adults with severe constipation.
    Cash BD; Sharma A; Walker A; Laitman AP; Chang L
    Neurogastroenterol Motil; 2023 Sep; 35(9):e14632. PubMed ID: 37332239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of medical costs generated by IBS patients in primary and secondary care in the Netherlands.
    Flik CE; Laan W; Smout AJ; Weusten BL; de Wit NJ
    BMC Gastroenterol; 2015 Nov; 15():168. PubMed ID: 26612205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Irritable bowel symptoms, use of healthcare, costs, sickness and disability pension benefits: A long-term population-based study.
    Poulsen CH; Eplov LF; Hjorthøj C; Hastrup LH; Eliasen M; Dantoft TM; Schröder A; Jørgensen T
    Scand J Public Health; 2019 Dec; 47(8):867-875. PubMed ID: 29762084
    [No Abstract]   [Full Text] [Related]  

  • 24. Burden of Constipation: Looking Beyond Bowel Movements.
    Harris LA; Chang CH
    Am J Gastroenterol; 2022 Apr; 117(4S):S2-S5. PubMed ID: 35354769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Costs of irritable bowel syndrome in the UK and US.
    Maxion-Bergemann S; Thielecke F; Abel F; Bergemann R
    Pharmacoeconomics; 2006; 24(1):21-37. PubMed ID: 16445300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower and Upper Gastrointestinal Symptoms Differ Between Individuals With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation.
    Shah ED; Almario CV; Spiegel BMR; Chey WD
    J Neurogastroenterol Motil; 2018 Apr; 24(2):299-306. PubMed ID: 29605985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blunted Evoked Prouroguanylin Endocrine Secretion in Chronic Constipation.
    Waldman SA; Tenenbaum R; Foehl HC; Winkle P; Griffin P
    Clin Transl Gastroenterol; 2019 Jul; 10(7):e00016. PubMed ID: 31318728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice.
    Johansson PA; Farup PG; Bracco A; Vandvik PO
    BMC Gastroenterol; 2010 Mar; 10():31. PubMed ID: 20233451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of somatization on the use of gastrointestinal health-care resources in patients with irritable bowel syndrome.
    Spiegel BM; Kanwal F; Naliboff B; Mayer E
    Am J Gastroenterol; 2005 Oct; 100(10):2262-73. PubMed ID: 16181379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents.
    Tse Y; Armstrong D; Andrews CN; Bitton A; Bressler B; Marshall J; Liu LW
    Can J Gastroenterol Hepatol; 2017; 2017():8612189. PubMed ID: 28271055
    [No Abstract]   [Full Text] [Related]  

  • 31. Irritable bowel syndrome with constipation: a European-focused systematic literature review of disease burden.
    Fortea J; Prior M
    J Med Econ; 2013; 16(3):329-41. PubMed ID: 23216014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
    Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
    Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Healthcare spending and utilization for pediatric Irritable Bowel Syndrome in a commercially insured population.
    Beinvogl B; Palmer N; Kohane I; Nurko S
    Neurogastroenterol Motil; 2021 Nov; 33(11):e14147. PubMed ID: 33818857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak.
    Zanini B; Ricci C; Bandera F; Caselani F; Magni A; Laronga AM; Lanzini A;
    Am J Gastroenterol; 2012 Jun; 107(6):891-9. PubMed ID: 22525306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The economic consequences of irritable bowel syndrome: a US employer perspective.
    Leong SA; Barghout V; Birnbaum HG; Thibeault CE; Ben-Hamadi R; Frech F; Ofman JJ
    Arch Intern Med; 2003 Apr; 163(8):929-35. PubMed ID: 12719202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis.
    Suares NC; Ford AC
    Am J Gastroenterol; 2011 Sep; 106(9):1582-91; quiz 1581, 1592. PubMed ID: 21606976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct medical costs of constipation from childhood to early adulthood: a population-based birth cohort study.
    Choung RS; Shah ND; Chitkara D; Branda ME; Van Tilburg MA; Whitehead WE; Katusic SK; Locke GR; Talley NJ
    J Pediatr Gastroenterol Nutr; 2011 Jan; 52(1):47-54. PubMed ID: 20890220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of linaclotide compared to antidepressants in the treatment of irritable bowel syndrome with constipation in Scotland.
    Fisher M; Walker A; Falqués M; Moya M; Rance M; Taylor D; Lindner L
    Eur J Health Econ; 2016 Dec; 17(9):1091-1100. PubMed ID: 26728984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment patterns and health care costs of mebeverine-treated IBS patients: a case-control study.
    Goettsch WG; van den Boom G; Breekveldt-Postma NS; Smout AJ; Herings RM
    Pharmacoepidemiol Drug Saf; 2004 Nov; 13(11):803-10. PubMed ID: 15386693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New treatment targets for the management of irritable bowel syndrome.
    Rao S; Weber HC
    Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):9-14. PubMed ID: 24300740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.